Prognosis and survival for clear cell renal cell carcinoma, breast cancer and prostate cancer are linked with LPCAT1 expression; it is useful as a diagnostic biomarker for prostate and esophageal cancers. The gene discussed is LPCAT1; the disease is prostate carcinoma.